Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Nusantara Sejahtera Raya Tbk. (CNMA) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Nusantara Sejahtera Raya Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Nusantara Sejahtera Raya Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Nusantara Sejahtera Raya Tbk. trades at Rp95 (market cap 7.92T, 35.79M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: Nusantara Sejahtera Raya Tbk. is far larger — about 48.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Nusantara Sejahtera Raya Tbk. is more actively traded (35.79M versus 62.5K). Which is the better fit depends on your goals.

CNMAOBAT
Market Cap
7.92T164.65B
Volume
35.79M62.5K
Lot
357.9K625
Turnover
3.37B15.03M
Average Price
94.07240.55
Value
3.37B15.03M
Indicative Equilibrium Price
95238
Indicative Equilibrium Volume
5.59K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CNMA
View details
OBAT
View details

About Nusantara Sejahtera Raya Tbk.

PT Nusantara Sejahtera Raya Tbk. (the “Company”) an Indonesian domiciled company, established on 7 June 1988 by deed of establishment No. 67, drawn up by Benny Kristianto, S.H. The Company commenced its commercial operations in 1989.

Read more on CNMA

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT